INTRODUCTION {#S1}
============

Renal epithelial cells contribute to tubule remodeling following kidney injury ([@R13]), long-term diuretic treatment ([@R9]), and genetic manipulation of tubule signaling pathways ([@R5], [@R7]). Tubule remodeling has been shown to associate with the production of autocrine and paracrine factors that may contribute to transport activation and hypertrophy, thereby protecting homeostasis ([@R6]). Tubule hypertrophy, primarily of the collecting duct, has been reported during chronic hypokalemia ([@R4]), yet the recent recognition of a unique role for the distal convoluted tubule (DCT) in rapid potassium adaptation ([@R27]; [@R31]) suggests that this nephron segment is especially sensitive. In line with this, molecular and anatomic changes are required for renal adaptation to occur following potassium stress, largely because dietary potassium deprivation leads to increased blood pressure ([@R27]). In the current model, hypokalemia is sensed by DCT cells via the basolateral potassium channel Kir4.1, thereby activating the thiazide-sensitive sodium-chloride cotransporter (NCC) and decreasing potassium secretion along more distal segments ([@R3]; [@R27]).

In humans, loss-of-function mutations in the gene encoding Kir4.1 cause seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME) syndrome (OMIN: 612780) or epilepsy, ataxia, sensorineural deafness, and tubulopathy (EAST) syndrome ([@R1]), with a tubulopathy that mimics Gitelman syndrome (caused by NCC dysfunction) (OMIN: 263800); this tubulopathy is characterized by unrelenting potassium wasting and low blood pressure, testifying to the critical role of this nephron segment ([@R25]). These disease characteristics suggest that NCC abundance and functional activity are tightly coupled to that of Kir4.1 ([@R3]). Interestingly, it has been reported that constitutive NCC ablation causes DCT atrophy ([@R14]), which likely contributes importantly to the clinical features of EAST or Gitelman syndromes. The hypothesis that activity along the DCT leads to morphological effects is supported by stereometric studies demonstrating that constitutive NCC activation increases the length of the DCT, whereas constitutive NCC inhibition shortens it ([@R5], [@R7]). However, these studies involved constitutive genetic manipulations that are likely to have substantial developmental effects. Additionally, observations regarding tubule remodeling in the DCT and other segments were made using two-dimensional techniques, which suffer from inherent biases. Here, we tested the hypothesis that short-term alterations in potassium balance lead to rapid tubule remodeling using two different models: dietary potassium deprivation and induced disruption of the DCT potassium sensor Kir4.1 ([@R3]). To address this question in an unbiased manner and thereby perform a more efficient and comprehensive analysis of tubule remodeling, we adapted whole-mount immunolabeling with highly validated and specific antibodies, optimized optical clearing methods, and advanced light microscopy for three-dimensional analysis of complete individual tubules. We focused on two main readouts of tubule remodeling (cell number and tubule length) and used two different optimized optical clearing methods (CLARITY and ethyl cinnamate \[ECi\]) ([@R2]; [@R10]). Here, we report determination of tubule remodeling in three dimensions by deep imaging of transparent mouse kidney slices and whole kidneys with confocal and light sheet microscopy.

RESULTS AND DISCUSSION {#S2}
======================

Tubule remodeling is an extremely dynamic process driven by constant physiological and morphological changes in the adult kidney. Most low-potassium diet studies have examined the long-term effects on kidney structure ([@R4]; [@R8]; [@R22]). Therefore, we restricted dietary potassium in wild-type mice for only 3 days and first used traditional two-dimensional techniques to analyze effects of diet on cell proliferation. A low-potassium diet reduced blood potassium levels compared to a normal-potassium diet ([Figures 1A and 1B](#F1){ref-type="fig"}). Compared with mice on a normal potassium diet, mice on a low-potassium diet exhibited more proliferating cells as detected by bromodeoxyuridine (BrdU) labeling (which labels cells in S phase) and Ki-67 expression (which labels all proliferating cells); these were mainly localized in the proximal tubules (preferentially S3 segments; [Figures 1C, 1F, and 1G](#F1){ref-type="fig"}), early parts of the DCT (DCT1; [Figures 1D and 1H](#F1){ref-type="fig"}), and collecting ducts (preferentially in the medulla; [Figures 1E and 1I](#F1){ref-type="fig"}). Additional proliferation in the peritubular space likely represents inflammatory cells ([Figure 1C](#F1){ref-type="fig"}). Prolonged hypokalemia is known to cause hypokalemic nephropathy, characterized by tubule injury, hyperplasia of mainly medullary collecting ducts, interstitial macrophage infiltration, and tubulointerstitial fibrosis in animals and humans ([@R8]; [@R22]). No obvious proliferation was detected in other tubule segments ([Figures S1 and S2](#SD1){ref-type="supplementary-material"}). As summarized in [Figures S1G and S2G](#SD1){ref-type="supplementary-material"}, these data suggest segment-specific tubule remodeling after 3 days of dietary potassium restriction and extend previous findings with prolonged hypokalemia. [@R4] demonstrated that kidney weight was 31% higher on an 18-day potassium-free diet and that hypertrophy was predominantly seen along the medullary collecting duct. Interestingly, endocycle-mediated hypertrophy, a phenomenon by which cells undergo DNA synthesis without cell division, has been recently uncovered in kidney tissue upon acute kidney injury ([@R12]). Further studies are needed to determine the role of endocycles in kidney growth upon chronic potassium restriction. Our observation that a low-potassium diet caused cellular hyperplasia in the DCT suggests that rapid tubule remodeling may be a normal homeostatic mechanism. The high incidence of proliferating cells found in the DCTs of mice on a low-potassium diet also supports the proposal that tubule remodeling is required to maintain homeostasis ([@R7]).

After confirming that 3 days of a low-potassium diet was sufficient to induce proliferation in various nephron segments, we performed optical clearing of kidney tissue to assess the overall number of proliferating cells by determining the number of BrdU^+^ cells ([Figure 2A](#F2){ref-type="fig"}). In thick ethyl cinnamate-cleared kidney slices from control mice, cell proliferation was mainly restricted to the cortex ([Figures 2B and 2D](#F2){ref-type="fig"}) and the outer stripe of the outer medulla ([Figures 2C and 2E](#F2){ref-type="fig"}; [Video S1](#SD2){ref-type="supplementary-material"}). However, after 3 days on a low-potassium diet, the number of proliferating cells was increased in the cortex and more dramatically in the outer medulla (both the outer and inner stripe) ([Figures 2B--2E](#F2){ref-type="fig"}). Because preferential hyperplasia occurred in medullary collecting duct cells, an antibody against aquaporin-2 (AQP2), a water channel specifically expressed in connecting tubules and collecting ducts, was used in both CLARITY- and ethyl cinnamate-cleared kidney slices ([Figures 3A and 3B](#F3){ref-type="fig"}). We co-stained BrdU and AQP2 in ethyl cinnamate-cleared kidney slices to determine all BrdU^+^ cells and those within the AQP2^+^ tubules ([Figure 3C](#F3){ref-type="fig"}; Video [S2](#SD3){ref-type="supplementary-material"} and [S3](#SD4){ref-type="supplementary-material"}). In normal kidneys, \~6% of all BrdU^+^ cells were localized in medullary collecting ducts, whereas the proportion of proliferating cells in medullary collecting ducts from low-potassium-diet mice was higher ([Figures 3C--3H](#F3){ref-type="fig"}). No signal was detected when kidneys were immersed in secondary antibody without previous incubation in primary antibody ([Figures 3I and 3J](#F3){ref-type="fig"}). These results demonstrate that the combination of whole-mount immunolabeling, optical clearing, and advanced light microscopy allows for the performance of three-dimensional analysis of segment-specific tubule hyperplasia. This opens up many new areas of kidney research in both normal and diseased kidneys.

Using stereometric and other two-dimensional techniques, several studies in transgenic mice indicated that decreased NCC activity is associated with decreased DCT length and vice versa ([@R5], [@R7]; [@R11]; [@R14]; [@R16]). We observed that short-term dietary potassium restriction, which induces NCC activation via Kir4.1 ([@R3]; [@R27]), causes DCT cell proliferation. We hypothesized, therefore, that kidney-specific deletion of *Kir4.1* in adult mice, which we have shown decreases NCC activity by preventing DCT cells from sensing plasma \[potassium\], causes shortening of the DCT. By using pThr53-NCC antibody and propidium iodide (PI), we were able to detect DCTs and all nuclei in CLARITY-cleared kidneys ([Figures 4A and 4B](#F4){ref-type="fig"}). We visualized and measured the length of entire DCTs, which exhibited substantial variability in lengths within the same kidney ([Figures 4C and 4D](#F4){ref-type="fig"}; [Video S4](#SD5){ref-type="supplementary-material"}). As predicted, DCTs were significantly shorter in *Kir4.1* KO mice than in controls ([Figure 4E](#F4){ref-type="fig"}), again, documenting tubule remodeling. No signal was detected when kidneys were immersed in secondary antibody without previous incubation in pThr53-NCC antibody ([Figures 4F and 4G](#F4){ref-type="fig"}).

To date, the best method to estimate tubule length is stereology, which estimates the length of a tubule segment based on systemic sampling of the kidney ([@R18]). This time-consuming procedure requires a high level of training and cannot visualize complete tubules ([@R20]). This approach was used previously to estimate mouse DCT lengths from a three-dimensional reconstruction of 2,500 thick consecutive sections ([@R32]). Here, we show that optical clearing combined with antibody labeling can be used to determine tubule length. In control mice, the length of the DCTs, using the accepted definition of segments that express NCC, was \~600 μm; this value is close to that estimated using the cumbersome and inferential reconstruction approach ([@R32]). We also observed a significant shorting of the DCT after 5 weeks of *Kir4.1* deletion in adult mice, demonstrating that tubule remodeling is assessable with our approach.

We used two different optical clearing strategies, solvent based (ethyl cinnamate) and hydrogel embedded (CLARITY), and imaged with two different microscopes (confocal and light sheet). Since access to the light sheet is limited in many laboratories, we demonstrate that any laboratory with access to a confocal microscope can visualize and analyze intact kidney tubules. However, while confocal or two-photon microscopes give higher-resolution images and might be used preferentially to analyze tissue with single-cell resolution, their slow scanning speeds and limited penetration depth make them unrealistic for imaging large fields of view or whole organs. Light sheet microscopy is a superior option owing to its high imaging speed, reduced sample bleaching, and large fields of view ([@R28]), which are required to visualize intact long tubule segments such as proximal tubules, thick ascending limbs, or collecting ducts. CLARITY and ethyl cinnamate are only two of the clearing approaches currently available, all of which have strengths and limitations in this rapidly growing field ([@R20]). Most of these clearing approaches have been developed with a focus in neurobiology ([@R23]), with only a few studies validating their application in other organs including the kidney ([@R10]; [@R19]; [@R21]). CLARITY is ideal to visualize endogenous fluorescence of reporters such as GFP, which is partially quenched by solvent-based clearing (e.g., ethyl cinnamate) ([@R10]; [@R20]). However, such reporters can also be visualized by antibody labeling, given the stability of fluorescent secondary antibodies and modified solvent-based protocols that preserve endogenous fluorescence signals ([@R15]). In contrast to the original ethyl cinnamate protocol ([@R10]), our approach combines a modified ethyl cinnamate optical clearing method and immunolabeling, which uses an antigen-retrieval step to improve antibody binding. In the case of poor antibody penetration, however, the CLARITY protocol, which includes a lipid removal step, may be employed.

For quantitative analyses, we used sliced adult kidneys for several reasons. First, multiple questions can be addressed by staining kidney slices from one kidney with different antibodies. Second, the use of slices saves time and is more cost effective, because less time and antibody are needed to penetrate the tissue. Third, volume imaging generates large datasets (up to several terabytes), which makes it impossible for most workstations to perform complex algorithms such as automated counting, spot-to-surface measurements, or object tracing. Therefore, image stacks from smaller tissues or subsets of bigger files are more manageable to perform three dimensional (3D) analysis.

In conclusion, we demonstrate by a combination of whole-mount immunolabeling, optical clearing, advanced light microscopy, and three dimensional morphometric analysis that dietary potassium deprivation leads rapidly to tubule hyperplasia and an increase of proliferating cells in the tubulointerstitium. These specific changes occurred in various nephron segments, including the distal tubule, and might reflect an adaptive or maladaptive proliferative response upon potassium restriction, which is known to activate NCC and cause hypertension. In contrast, NCC inhibition by deletion of the potassium-sensor *Kir-4.1* caused distal tubule atrophy. Use of this comprehensive tool allows reliable and efficient analysis of individual tubule segments and is an ideal approach to better understand tubule remodeling.

STAR★METHODS {#S3}
============

CONTACT FOR REAGENT AND RESOURCE SHARING {#S4}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Turgay Saritas (<tsaritas@ukaachen.de>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S5}
--------------------------------------

### Mouse models {#S6}

Studies were approved by Oregon Health and Science University's Animal Care and Use Committee (Protocol IP00286). For the low potassium diet study, male and female C57BL/6 mice were used between 12--24 weeks of age (average weight: 25--30 g). All strains are backcrossed to the appropriate wild-type mice every ten generations to maintain genetic backgrounds. For the measurement of the distal convoluted tubule length, kidney-specific *Kcnj10* deletion was carried out in 8 to 12-week-old mice homozygous for the floxed *Kcnj10* gene ([@R3]) and hemizygous for the Pax8-rtTA/LC-1-Cre transgene ([@R29]) by providing doxycycline (2 mg/ml; Alfa Aesar, Cat\#J60579) in 5% sucrose/drinking water for 3 weeks. This was followed by at least 2 additional weeks of washout period, before performing experiments. Littermate mice of the same age and genetic background were given 5% sucrose via drinking water and were used as controls (*Kcnj10*^fl/fl^). The complete procedure and genotyping were previously reported ([@R3]). All mice were bred in-house and were group housed (up to 5 mice per cage).

METHOD DETAILS {#S7}
--------------

### Antibodies and chemicals {#S8}

A list of antibodies and chemicals including vendor and catalog numbers is provided in [Key Resources Table](#T1){ref-type="table"}.

### Low potassium diet {#S9}

For quantification of BrdU^+^ cells following normal or low potassium diet, mice were fed for 3 days with potassium-deficient diet (approx. 0.002% potassium; Envigo, Cat\#TD.88239) or normal potassium diet (1.2% potassium, Labdiet, Cat\#5LOD) and were injected with BrdU (40 mg/kg b.w.; Roche, Cat\#11296736001) intraperitoneally before kidneys were perfusion-fixed 4 h later. Water was provided *ad libitum*.

### Blood biochemistry {#S10}

Blood was collected via cardiac puncture under isoflurane anesthesia and transferred into heparinized tubes; 80 μL was immediately loaded into a Chem8+ cartridge for electrolyte measurement in an i-STAT analyzer (Abbot Point of Care Inc., Princeton, NJ, USA).

### Immunofluorescence of kidney sections {#S11}

Kidneys were fixed by retrograde abdominal aortic perfusion of 3% paraformaldehyde and embedded in paraffin. Four micrometer sections were dewaxed and rehydrated by successive immersion for 5 min in 100% xylene, 100%, 90% and 70% ethanol solutions. Following heat-induced citrate-based antigen retrieval (Vector Laboratories, Cat\#H-3300), immunostaining was performed using the following primary antibodies in 1% BSA/PBS (BrdU, Roche, Cat\#11296736001; Ki-67, Vector Laboratories, Cat\#VP-RM04; AQP2, Santa Cruz Biotechnology, Cat\#sc-9882; pThr53-NCC (generated in laboratory of D.H.E; commercially available from Phosphosolution, Cat\#p1311-53 ([@R16]; [@R17])); total Na^+^-potassium-2Cl^−^ (NKCC2) and pT96/T101-NKCC2 (gift from Sebastian Bachmann, ([@R24])); Pendrin (gift from Susan Wall, ([@R30])). Fluorescein-labeled Lotus Tetragonolobus Lectin (LTL-FITC; Vectorlabs, Cat\#FL-1321) was used to identify proximal tubules ([@R26]). Cy2-, Cy3-, or Cy5-conjugated antibodies (Thermo Fisher Scientific) served as secondary antibodies and 4',6-Diamidino-2-phenylindole-containing mounting medium (Thermo Fisher Scientific, Cat\#P36971) was used for nuclear staining. 12 images from each kidney section were captured at 100× magnification on a Carl Zeiss AxioImager.M2 using AxioVision SE64 software.

### Optical clearing of the kidney {#S12}

PFA perfusion-fixed kidneys, cut into either 1-2 mm thick kidney slices or kept whole ([Figure 2A](#F2){ref-type="fig"}), were post-fixed in PFA for at least 3 days at room temperature, then washed in 1× wash buffer (Agilent, Envision Flex Wash Buffer, Cat\#K800721-2) and placed on a horizontal shaker overnight at room temperature. Then, one of the two following kidney-optimized protocols was used:

#### Ethyl cinnamate {#S13}

We applied our recently published immunoflourescence protocol on thick kidney slices ([@R19]). Antigen retrieval was performed using antigen retrieval solution (Vector Laboratories, Cat\#H-3300) for 1 hour at 92-98°C then the slices were left to cool. After a wash in wash buffer overnight at room temperature, slices were immersed in 500 μL primary antibody solution made up in antibody diluent (Dako, Cat\#S0809) using BrdU (1:100; Roche, Cat\#11296736001) and/or AQP2 (1:150; Santa Cruz Biotechnology, Cat\#sc-9882) at 37°C for 4 days. Slices were then washed in wash buffer for 24 hours with one change of wash buffer after 8 hours. Next, slices were immersed in 500 μL secondary antibody solution made up in antibody diluent using a donkey anti--goat Cy3 (to detect AQP2) (1:200; Life Technologies, Cat\#A21432) and a donkey anti--mouse Cy5 (to detect Brdu) (1:200; Life Technologies, Cat\#A31571). Slices were washed again in wash buffer on an orbital shaker for 24 hours with one change of wash buffer after 8 hours, then placed in high grade 100% ethanol (Merck; Cat\#100983) for 1hr at room temperature with gentle shaking (with at least one change to fresh ethanol). They were directly immersed in ethyl cinnamate (Sigma-Aldrich; Cat\#112372) and gently agitated overnight at room temperature under light protection. Tissue translucency was achieved in less than 1hr. In contrast to Klingberg et al. ([@R10]), we did not immerse kidney slices in sequential ascending ethanol dilutions, which saved time and increased efficiency.

#### CLARITY {#S14}

We modified a previously published protocol by Chung et al. ([@R2]). Kidney slices or whole kidney were immersed in hydrogel monomer solution (4% acrylamide (Bio-Rad, Cat\#161-0140), 0.25% Azo initiator (Wako, Cat\#VA-044), 1× PBS, and 4% PFA (Thermo Fischer Scientific, Cat\#O4042-500) in UltraPure water) at 4°C for 3 or 7 days, respectively. Hydrogel polymerization was induced under argon atmosphere (O~2~ free) at 37°C for 3hrs. Samples were washed with 1× wash buffer overnight at room temperature, then placed in Smart Clear II Pro (Lifecanvas Technologies) for 3 days (kidney slices) or 7 days (whole kidney). Samples were washed with 1× wash buffer overnight at room temperature, then immunofluorescence protocol was performed as described in the ethyl cinnamate section with the exception that we did not perform antigen retrieval, and tissue was stained with pThr53-NCC (1:100) or propidium iodide (PI, 1:1000, Life Technologies, Cat\#P3566). pThr53-NCC-stained samples were washed overnight and then incubated with donkey anti--rabbit Cy5 (1:200; Life Technologies, Cat\#A31573) for 4 days. Imaging was performed after at least 24hrs of incubation in Easy Index clearing solution (Lifecanvas Technologies, Cat\#EI-Z1001).

For ethyl cinnamate-cleared samples we used a confocal microscope (Zeiss LSM 880 with Airyscan, 10× objective lens). From each kidney slice, five z stacks were taken from both cortex and outer medulla (approximately covering 50% outer stripe (OSOM), 50% inner stripe (ISOM)). For each experiment, two kidney slices per animal were used. Fluorescence signal was generated by excitiation at 555nm and 647nm using a DPSS 561 and a HeNE laser. For imaging of CLARITY-cleared samples, we used a light sheet microscope (Zeiss Z1, 5× and 20× CLARITY-optimized objective lenses). 7-10 z stacks were taken from cortex of each kidney slice, and two kidney slices per animal were used. For both microscopes Zen software (Carl Zeiss) was used.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S15}
---------------------------------------

For quantification of the number of BrdU^+^ or Ki-67^+^ cells on thin kidney sections, 12 images (100× field) were randomly taken per cortex and outer medulla. The number of cells was counted using ImageJ and expressed as number of cells per field.

For quantification of sample volume, BrdU^+^ cells (spots) and DCT length (length of connected measurement points) were performed using three dimensional rendering and analysis software (Imaris, v9.2.1; Bitplane, AG). The following criteria were set for the analysis of BrdU spots: size 8 μm in xy-axis, 14 μm in z axis (values were determined by measuring diameter in xy axis in 2D/slice view, and length in z axis using three dimensional view). DCTs touching the boundary of the section were excluded since they could represent incomplete tubules. Three dimensional rendering of PI^+^ nuclei, AQP2^+^ and pThr53-NCC^+^ tubules was performed using Arivis Vision4D (Arivis AG). Statistical parameters including the exact value of n, the definition of center, dispersion and precision measures (mean ± SEM) and statistical significance are reported in the Figures and Figure Legends. Data was judged to be statistically significant when p \< 0.05 by parametric unpaired two-tailed Student's t test. Statistical analysis was performed in GraphPad PRISM 6 (GraphPad software Inc., La Jolla, CA).

Supplementary Material {#SM1}
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![Effects of a 3-Day Low-Potassium Diet\
(A) Adult C57BL/6J mice were fed for 3 days with a low-potassium diet or normal-potassium diet and then injected with bromodeoxyuridine (BrdU) intraperitoneally before kidneys were perfusion fixed 4 hr later.\
(B) Blood potassium levels were lower in mice fed a low-potassium diet than in mice fed a normal-potassium diet.\
(C) Immunofluorescence of 4-μm-thin sections revealed that a low-potassium diet increased the number of proliferating cells (BrdU \[cells in S-phase\] and Ki-67 \[cells in G1, S, G2, or M-phase\]) in the proximal tubule (LTL^+^, arrows) and other tubules or the peritubular space (arrowhead). Scale bar, 100 μm.\
(D and E) A low-potassium diet induced a strong proliferative response in parvalbumin^+^ early distal convoluted tubule (DCT1) (D) and AQP2^+^ medullary collecting duct (E).\
(F and G) Quantification of (C).\
(H) Quantification of (D).\
(I) Quantification of (E).\
12 fields at 100× magnification were quantified from each sample.\
Data are represented as mean ± SEM (n = 6--7 mice). p values were calculated using an unpaired two-tailed Student's t test. ISOM, inner stripe of the outer medulla; OSOM, outer stripe of the outer medulla; PV, parvalbumin.](nihms-1516648-f0002){#F1}

![Optical Clearing and BrdU^+^ Cells in Ethyl-Cinnamate-Cleared Kidney Slices\
(A) PFA-fixed kidneys were either sliced in thick slices or not sectioned, and then two different protocols were applied. For CLARITY, tissue was immersed in hydrogel monomer solution, polymerization was induced, and then tissue was cleared. For ethyl cinnamate (ECi), antigen retrieval was performed. In both protocols, tissue was then stained with antibodies or dye and optical clearing was performed using CLARITY (easy clear index solution) or ethyl cinnamate. Confocal and light sheet microscopy were used for volume imaging. Note that different kidneys are shown here.\
(B and C) Three-dimensional visualization of a representative z stack shows an increased number of BrdU^+^ cells in the cortex (B) and outer medulla (C) in mice on a low-potassium diet compared to mice on a normal-potassium diet. ISOM, inner stripe of the outer medulla; OSOM, outer stripe of the outer medulla.\
(D and E) Quantification of (B) and (C). Two kidney slices per sample were used, and from each kidney slice, five z stacks were taken from both the cortex (D)and outer medulla (E) (covering \~50% of the outer stripe \[OSOM\] and 50% of the inner stripe \[ISOM\]). Imaging was performed with confocal microscopy using a 10× objective lens (Zeiss LSM 880 with Airyscan).\
Data are represented as mean ± SEM (n = 6 mice). p values were calculated using the unpaired two-tailed Student's t test. Scale bar, 100 μm. See also [Video S1](#SD2){ref-type="supplementary-material"} (outer medulla under low potassium diet).](nihms-1516648-f0003){#F2}

![BrdU^+^ Cells in AQP2^+^ Tubules\
(A) AQP2^+^ tubules in CLARITY-cleared control kidney. Scale bars, 1 mm.\
(B) AQP2^+^ tubules in control kidney. The CLARITY protocol was first applied, and then tissue was washed, dehydrated, and cleared with ethyl cinnamate. Scale bar, 200 μm.\
(C--D) Ethyl cinnamate-cleared kidney slices from mice on 3-day normal (C) or low (D) potassium diet were co-stained for AQP2 and BrdU.\
(E--G) Data analysis process to determine BrdU^+^ cells within the AQP2^+^ medullary collecting duct in mice on low potassium diet.\
(H) Quantification of BrdU^+^ cells within the AQP2^+^ medullary collecting duct in mice on normal (C) or low (D) normal and low-potassium diets. Two kidney slices per sample were used, and from each kidney slice, five z stacks were taken from the outer medulla (covering \~50% of the outer stripe \[OSOM\] and 50% of the inner stripe \[ISOM\]). Imaging was performed with confocal microscopy using a 10× objective lens (Zeiss LSM 880 with Airyscan). Data are represented as mean ± SEM (n = 3 mice). p values were calculated using an unpaired two-tailed Student's t test.\
(I and J) A representative z stack shows an absence of nonspecific binding of secondary antibody (I, donkey anti-mouse Cy5 \[pseudocolor: red\]; J, donkey anti-goat Cy3 \[pseudocolor: green\]) without previous incubation in primary antibody. Scale bars, 100 μm.\
Imaging was performed with a Zeiss Light Sheet Z1 using a 5× objective lens (A) and confocal microscopy using a 10× objective lens (B--G). See also Videos [S2](#SD3){ref-type="supplementary-material"} and [S3](#SD4){ref-type="supplementary-material"}.](nihms-1516648-f0004){#F3}

![Quantification of DCT Length in Control and *Kir4.1* Knockout Mice\
(A) Visualization of pThr53-NCC^+^ DCTs and all nuclei using propidium iodide (PI) in whole optical cleared control kidney. Glomeruli are visible as bright red dots due to a higher density of PI^+^ nuclei within glomeruli than surrounding tissue. Scale bar, 1 mm.\
(B) One slice of a z stack showing apical staining of DCT and all nuclei using pThr53-NCC and PI. Scale bar, 100 μm.\
(C) Low-magnification visualization of pThr53-NCC^+^ DCTs. The z stack was taken along the cortical kidney surface. Scale bar, 300 μm.\
(D) High-magnification visualization shows individual DCTs. The length was measured after three dimensional rendering using measurement points in Imaris software (white lines). Scale bar, 50 μm.\
(E) Quantification of (D) shows that *Kir4.1* deletion is associated with a shortening of the DCT compared to controls (CTRL).\
(F) One slice of a z stack showing all nuclei using PI and absence of nonspecific binding of secondary antibody (Ab) (donkey anti-rabbit Cy5) without previous incubation in pThr53-NCC antibody. Scale bar, 100 μm.\
(G) No signal was detected in secondary antibody-only experiments (donkey anti-rabbit Cy5; pseudocolor: green) in ethyl cinnamate-cleared kidneys. Scale bar, 100 μm. 7--10 z stacks were taken with a 20× objective lens from the cortex of each kidney slice, and two kidney slices per animal were used.\
Data are represented as mean ± SEM (n = 3 mice). p values were calculated using an unpaired two-tailed Student's t test. Imaging was performed with Zeiss Light Sheet Z1 using 5× (A) and 20× objective lenses (B--D and F). Zeiss LSM 880 confocal microscopy was used to take the image shown in (G). See also [Video S4](#SD5){ref-type="supplementary-material"}.](nihms-1516648-f0005){#F4}

###### KEY RESOURCES TABLE

  ------------------------------------------------------------------------------------------------------------------------------------------------
  REAGENT or RESOURCE                               SOURCE                                                        IDENTIFIER
  ------------------------------------------------- ------------------------------------------------------------- --------------------------------
  Antibodies                                                                                                      

  Anti-BrdU monoclonal antibody                     Roche                                                         Cat\#11296736001

  Rabbit anti-Ki-67                                 Vector Laboratories                                           Cat\#VP-RM04; RRID: AB_2336545

  Goat anti-AQP2                                    Santa Cruz Biotechnology                                      Cat\#sc-9882; RRID: AB_2289903

  Rabbit anti-phoshoThr53-NCC                       PhosphoSolutions                                              Cat\#p1311-53; RRID:AB_2650477

  Guinea pig anti-NKCC2                             [@R24]                                                        N/A

  Rabbit anti-pT96/T101-NKCC2                       [@R24]                                                        N/A

  Guinea pig anti-pendrin                           [@R30]                                                        N/A

  Guinea pig anti-parvalbumin                       Swant                                                         Cat\#GP72; RRID: AB_2665495\
                                                                                                                  RRID:AB_2665495

  Mouse anti-calbindin D-28k                        Swant                                                         Cat\#300; RRID: AB_10000347

  Donkey anti--goat Cy3                             Life Technologies                                             Cat\#A21432; RRID:AB_141788

  Donkey anti--mouse Cy5                            Life Technologies                                             Cat\#A31571; RRID: AB_162542

  Donkey anti--rabbit Cy5                           Life Technologies                                             Cat\#A31573; RRID: AB_2536183

  Chemicals                                                                                                       

  Fluorescein labeled Lotus Tetragonolobus Lectin   Vectorlabs                                                    Cat\#FL-1321; RRID: AB_2336559

  Propidium iodide                                  Life Technologies                                             Cat\#P3566

  Doxycycline                                       Alfa Aesar                                                    Cat\#J60579

  Citrate-based antigen retrieval solution          Vector Laboratories                                           Cat\#H-3300; RRID:AB_2336226

  DAPI mounting medium                              Thermo Fischer Scientific                                     Cat\#P36971

  Envision Flex Wash Buffer                         Agilent                                                       Cat\#K800721-2

  Antibody diluent                                  Dako                                                          Cat\#S0809

  Ethanol                                           Merck                                                         Cat\#100983

  Ethyl cinnamate                                   Sigma-Aldrich                                                 Cat\#112372

  Acrylamide                                        Bio-Rad                                                       Cat\#161-0140

  Azo initiator                                     Wako                                                          Cat\#VA-044

  Paraformaldehyde                                  Thermo Fischer Scientific                                     Cat\#O4042-500

  Easy Index clearing solution                      Lifecanvas Technologies                                       Cat\#EI-Z1001

  Experimental Models: Organisms/Strains                                                                          

  Mouse: Pax8-rtTA/LC-Kcnj10fl/fl                   [@R3]                                                         N/A

  Mouse: C57BL/6J                                   The Jackson Laboratory                                        Stock No: 000664

  Software and Algorithms                                                                                         

  Imaris                                            <http://www.bitplane.com/imaris/imaris>                       N/A

  Arivis 4D                                         <https://www.arivis.com/en/imaging-science/arivis-vision4d>   N/A

  GraphPad Prism                                    <https://www.graphpad.com/scientific-software/prism/>         N/A

  Other                                                                                                           

  Potassium-deficient diet                          Envigo                                                        Cat\#TD.88239

  Normal potassium diet                             Labdiet                                                       Cat\#5LOD
  ------------------------------------------------------------------------------------------------------------------------------------------------

###### Highlights

-   Tubule remodeling is assessable by immunolabeling optically cleared mouse kidneys

-   A low-potassium diet leads to proliferation of various nephron segments

-   Hyperplasia occurs in the proximal and distal tubules and medullary collecting duct

-   Deletion of the renal potassium sensor Kir4.1 causes distal convoluted tubule atrophy
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